Biomarin Pharmaceutical Inc (BMRN)

03:28 AM

BMRN stock touches 52-week low at $60.63 amid market shifts - Investing.com Australia

03:28 AM

09:47 AM

BioMarin succeeds in trial for its metabolic disorder treatment - MSN

09:47 AM

Apr 03, 2025

Edmond DE Rothschild Holding S.A. Boosts Stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) - MarketBeat

Apr 03, 2025

Apr 03, 2025

BioMarin Pharmaceutical: Pegasus Success May Lead To Palynziq Label Expansion (BMRN) - Seeking Alpha

Apr 03, 2025

Apr 03, 2025

BMRN's PKU Drug Palynziq Meets Goal in Late-Stage Pediatric Study - Yahoo Finance

Apr 03, 2025

Apr 03, 2025

Nomura Asset Management Co. Ltd. Sells 73,310 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) - MarketBeat

Apr 03, 2025

Apr 02, 2025

BioMarin’s PALYNZIQ shows promise for adolescents with PKU - Investing.com India

Apr 02, 2025

Apr 02, 2025

BioMarin’s PALYNZIQ shows promise for adolescents with PKU By Investing.com - Investing.com South Africa

Apr 02, 2025

Apr 02, 2025

BioMarin Seeks Label Expansion For Palynziq After Positive Phase 3 Results In Adolescent Patients - Benzinga

Apr 02, 2025

Apr 02, 2025

BioMarin's Trial for Phenylketonuria Shows Palynziq Reduces Blood Phenylalanine in Adolescents - MarketScreener

Apr 02, 2025

Apr 02, 2025

Is BioMarin Pharmaceutical Inc. (BMRN) The Most Profitable Biotech Stock To Buy Right Now? - Yahoo Finance

Apr 02, 2025

Apr 02, 2025

Is Royalty Pharma plc (RPRX) The Most Profitable Biotech Stock To Buy Right Now? - Yahoo Finance

Apr 02, 2025

Apr 02, 2025

Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Growth Stock - Yahoo Finance

Apr 02, 2025

Apr 02, 2025

BioMarin (BMRN) Beats on Q1 Earnings, Voxzogo Drives Sales - MSN

Apr 02, 2025

Apr 02, 2025

BioMarin Announces Positive Pivotal Data for PALYNZIQ® (pegvaliase-pqpz) in Adolescents with Phenylketonuria - PR Newswire

Apr 02, 2025

Mar 31, 2025

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Sold by Mitsubishi UFJ Trust & Banking Corp - MarketBeat

Mar 31, 2025

Mar 31, 2025

The Price Is Right For BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) - simplywall.st

Mar 31, 2025

Mar 30, 2025

11 Best Gene Therapy Stocks to Buy According to Analysts - Insider Monkey

Mar 30, 2025

Mar 28, 2025

US FDA approves Sanofi's bleeding disorder therapy - MarketScreener

Mar 28, 2025

Mar 28, 2025

Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Momentum Stock - Yahoo Finance

Mar 28, 2025

Mar 25, 2025

Is BioMarin Pharmaceutical Inc. (BMRN) a Promising Biotech Stock According to Wall Street Analysts - Insider Monkey

Mar 25, 2025

Mar 25, 2025

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Holdings Lifted by Sector Gamma AS - MarketBeat

Mar 25, 2025

Mar 22, 2025

Insider Sell Alert: Erin Burkhart Sells Shares of Biomarin Pharm - GuruFocus

Mar 22, 2025

Mar 21, 2025

BioMarin (BMRN) Up 4.2% Since Last Earnings Report: Can It Continue? - Yahoo Finance

Mar 21, 2025

Mar 21, 2025

Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Value Stock - Yahoo Finance

Mar 21, 2025

Mar 21, 2025

Q4 Earnings Review: Therapeutics Stocks Led by BioMarin Pharmaceutical (NASDAQ:BMRN) - Yahoo Finance

Mar 21, 2025

Mar 21, 2025

BioMarin pharmaceutical CAO Erin Burkhart sells $92,618 in stock By Investing.com - Investing.com Australia

Mar 21, 2025

Mar 20, 2025

BioMarin pharmaceutical CAO Erin Burkhart sells $92,618 in stock - Investing.com India

Mar 20, 2025

Mar 20, 2025

Citi maintains Neutral on BioMarin stock, price target at $82 - Investing.com

Mar 20, 2025

Mar 20, 2025

BioMarin Pharmaceutical (BMRN): Among Paul Singer’s Latest Portfolio’s Top Stock Picks - Insider Monkey

Mar 20, 2025

Mar 20, 2025

BioMarin Presents New Data Demonstrating Favorable Safety and Strong Adherence in Real-World Clinical Practice with VOXZOGO® (vosoritide) in Children Under 3 with Achondroplasia at 2025 American College of Medical Genetics and Genomics (ACMG) - PR Newswire

Mar 20, 2025

Mar 20, 2025

BioMarin's VOXZOGO Achieves Breakthrough Safety Milestone in Toddlers with Dwarfism - Stock Titan

Mar 20, 2025

Mar 18, 2025

BMRN vs. CSLLY: Which Stock Should Value Investors Buy Now? - Yahoo Finance

Mar 18, 2025

Mar 18, 2025

Is BioMarin Pharmaceutical (BMRN) the Best Biotech Stock According to Billionaires? - Yahoo Finance

Mar 18, 2025

Mar 16, 2025

15 Best Biotech Stocks to Buy According to Billionaires - Insider Monkey

Mar 16, 2025

Mar 12, 2025

Is BioMarin (BMRN) a Solid Growth Stock? 3 Reasons to Think "Yes" - Yahoo Finance

Mar 12, 2025

Mar 12, 2025

SpringWorks Shares Rise More Than 30% in 3 Months: Here's Why - TradingView

Mar 12, 2025

Mar 12, 2025

Wall Street Analysts Believe BioMarin (BMRN) Could Rally 36.57%: Here's is How to Trade - Yahoo Finance

Mar 12, 2025

Mar 12, 2025

Why BioMarin Pharmaceutical (BMRN) is a Top Momentum Stock for the Long-Term - Yahoo Finance

Mar 12, 2025

Mar 12, 2025

544 Shares in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Purchased by SBI Securities Co. Ltd. - Defense World

Mar 12, 2025

Mar 11, 2025

Smartleaf Asset Management LLC Increases Stock Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) - Defense World

Mar 11, 2025

Mar 10, 2025

4 Discounted PEG Stocks Offering the Best Returns to Value Investors - Yahoo Finance

Mar 10, 2025

Mar 10, 2025

BioMarin Pharmaceutical (NASDAQ:BMRN) Upgraded at StockNews.com - Defense World

Mar 10, 2025

Mar 09, 2025

BioMarin Pharmaceutical Inc. to Host Earnings Call - ACCESS Newswire

Mar 09, 2025

Mar 09, 2025

Proficio Capital Partners LLC Takes Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) - Defense World

Mar 09, 2025

Mar 07, 2025

The Top 12 Companies Hiring in Biopharma Now - BioSpace

Mar 07, 2025

Mar 06, 2025

BioMarin at TD Cowen Conference: Strategic Growth and Innovation - Investing.com

Mar 06, 2025

Mar 05, 2025

First Week of October 17th Options Trading For BioMarin Pharmaceutical (BMRN) - Nasdaq

Mar 05, 2025

Mar 05, 2025

Why BioMarin Pharmaceutical (BMRN) is a Top Value Stock for the Long-Term - Yahoo Finance

Mar 05, 2025